Beatrice Thier Selected Research

I-antigen

1/2021	Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance.
1/2020	Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beatrice Thier Research Topics

Disease

5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
4	Neoplasms (Cancer) 10/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

2	Differentiation AntigensIBA 01/2022 - 10/2021
2	I-antigenIBA 01/2021 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	InterferonsIBA 01/2021 - 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	PlasticsIBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	LigandsIBA 01/2021
1	AntibodiesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2020
3	Immunotherapy 10/2021 - 01/2020